Hepatitis viral en atención primaria

Stanaway, 2016, The global burden of viral hepatitis from 1990 to 2013 : findings from the Global Burden of Disease Study 2013, Lancet, 388, 1081, 10.1016/S0140-6736(16)30579-7 WHO Global Hepatitis Report 2017. https://creativecommons.org/licenses/by-nc-sa/3.0/igo. Havelaar, 2015, World Health Organization global estimates and regional comparisons of the burden of foodborne disease in 2010, PLoS Med, 12, 10.1371/journal.pmed.1001923 Pol, 2019, Présentation clinique et étiologie des hépatites, Traité de médecine, 1 European Association for Study of Liver, 2015, EASL-ALEH Clinical Practice Guidelines : non invasive tests for evaluation of liver disease severity and prognosis, J Hepatol, 63, 237, 10.1016/j.jhep.2015.04.006 Lemon, 2017, Type A viral hepatitis : A summary and update on the molecular virology, epidemiology, pathogenesis and prevention, J Hepatol Kamar, 2017, Hepatitis E virus infection, Nat Rev Dis Primer, 3, 17086, 10.1038/nrdp.2017.86 Kamar, 2014, Ribavirin for chronic hepatitis E virus infection in transplant recipients, N Engl J Med, 370, 1111, 10.1056/NEJMoa1215246 Wang, 2020, HBV genome and life cycle, Adv Exp Med Biol, 1179, 17, 10.1007/978-981-13-9151-4_2 European Association for the Study of the Liver, 2017, EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection, J Hepatol, 67, 370, 10.1016/j.jhep.2017.03.021 Terrault, 2018, Update on prevention, diagnosis, and treatment of chronic hepatitis B : AASLD 2018 Hepatitis B Guidance, Hepatology, 67, 1560, 10.1002/hep.29800 Sarin, 2016, Asian-Pacific clinical practice guidelines on the management of hepatitis B : a 2015 update, Hepatol Int, 10, 1, 10.1007/s12072-015-9675-4 Vallet-Pichard, 2021, Review article: immunisation against hepatitis B virus infection and the prevention of hepatocellular carcinoma, Aliment Pharmacol Ther, 53, 1166 Marcellin, 2013, Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study, Lancet, 381, 468, 10.1016/S0140-6736(12)61425-1 Revill, 2019, A global scientific strategy to cure hepatitis B, Lancet Gastroenterol Hepatol, 4, 545, 10.1016/S2468-1253(19)30119-0 Wedemeyer, 2010, Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead, Nat Rev Gastroenterol Hepatol, 7, 31, 10.1038/nrgastro.2009.205 Urban, 2014, Strategies to inhibit entry of HBV and HDV into hepatocytes, Gastroenterology, 147, 48, 10.1053/j.gastro.2014.04.030 Pol, 2019, The remarkable history of the hepatitis C virus, Microbes Infect, 21, 263, 10.1016/j.micinf.2019.06.008 European Association for the Study of the Liver (EASL) recommendations on treatment of hepatitis C: final update of the series. J Hepatol 2020;73(5):1170-218. AASLD-IDSA. Recommendations for testing, managing, and treating hepatitis C; 2017. http://www.hcvguidelines.org. Buhler, 2012, New targets for antiviral therapy of chronic hepatitis C, Liver Int, 32 Moradpour, 2007, Replication of hepatitis C virus, Nat Rev Microbiol, 5, 453, 10.1038/nrmicro1645 Roingeard, 2020, Hepatitis C Vaccine: 10 Good Reasons for Continuing, Hepatology, 71, 1845, 10.1002/hep.31182 Lee, 2012, Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study, J Infect Dis, 206, 469, 10.1093/infdis/jis385 Boerekamps, 2018, Declining hepatitis C virus (HCV) incidence in Dutch human immunodeficiency virus positive men who have sex with men after unrestricted access to HCV therapy, Clin Infect Dis, 66, 1360, 10.1093/cid/cix1007 Nahon, 2017, Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications, Gastroenterology, 152, 142, 10.1053/j.gastro.2016.09.009 Carrat, 2019, Clinical outcomes in patients with chronic hepatitis C following direct-acting antiviral therapy: A prospective cohort study, Lancet, 393, 1453, 10.1016/S0140-6736(18)32111-1 Lazarus, 2017, EASL International Liver Foundation. Micro-elimination - A path to global elimination of hepatitis C, J Hepatol, 67, 665, 10.1016/j.jhep.2017.06.033